Serial Studies of Hepatitis-Associated Antigen and Antibody in Patients Receiving Antitumor Chemotherapy for Myeloproliferative and Lymphoproliferative Disorders
- 1 January 1975
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 68 (1) , 105-112
- https://doi.org/10.1016/s0016-5085(75)80054-0
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- A possible relationship to treatment between hepatitis-associated antigen and chronic persistent hepatitis in Hodgkin's diseaseGut, 1973
- THYMUS-DEPENDENT LYMPHOCYTE FUNCTION IN PATIENTS WITH HEPATITIS-ASSOCIATED ANTIGENThe Lancet, 1972
- CELLULAR IMMUNITY AND HEPATITIS-ASSOCIATED, AUSTRALIA ANTIGEN LIVER DISEASEThe Lancet, 1972
- The Role of Australia Antigen in Viral Hepatitis and Other DiseasesAnnual Review of Medicine, 1972
- ROLE OF IMMUNE COMPLEXES INVOLVING SH ANTIGEN IN PATHOGENESIS OF CHRONIC ACTIVE HEPATITIS AND POLYARTERITIS NODOSAThe Lancet, 1971
- FREQUENCY OF AUSTRALIA ANTIGEN IN PATIENTS WITH LEUKÆMIA IN DIFFERENT COUNTRIESThe Lancet, 1971
- Hemagglutination Assay for Antigen and Antibody Associated with Viral HepatitisScience, 1970
- DNA polymerase activity as an index of lymphocyte stimulation: studies in Down's syndromeJournal of Clinical Investigation, 1970
- Potentiation of Experimental Arbovirus Encephalitis by Immunosuppressive Doses of CyclophosphamideNature, 1968
- A "New" Antigen in Leukemia SeraJAMA, 1965